We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Issues Final Rule on Discontinued Manufacturing Operations
U.S. FDA Issues Final Rule on Discontinued Manufacturing Operations
November 19, 2007
Pharmaceutical companies that are the sole manufacturers of life-sustaining drugs face a new U.S. Food and Drug Administration (FDA) rule that will require them to notify the agency six months in advance if they intend to discontinue producing the product.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor